A Phase II Combination Trial of PS-341 and 5-FU/LV in Gastric and/or GE Junction Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2010
At a glance
- Drugs Bortezomib (Primary) ; Fluorouracil; Folinic acid
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 11 Oct 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 15 Aug 2005 New trial record.